RB builds R&D on eight “science platforms”

1 March 2021 - Deborah Wilkes


Reckitt Benckiser (RB) is focusing on eight “science platforms” as it steps up investment in research and development across the organisation. The company says it is “doubling” the research and development spend for its OTC portfolio.

Click tags below for more information on topics:


Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: